thiophenes has been researched along with Cutaneous T-Cell Lymphoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmad, N; Nihal, M; Schmit, T; Stutz, N; Wood, GS | 1 |
Liu, X; Liu, XS | 1 |
Baron, P; Polsky, B; Prochaska, HJ; Yeh, Y | 1 |
3 other study(ies) available for thiophenes and Cutaneous T-Cell Lymphoma
Article | Year |
---|---|
Polo-like kinase 1 (Plk1) is expressed by cutaneous T-cell lymphomas (CTCLs), and its downregulation promotes cell cycle arrest and apoptosis.
Topics: Apoptosis; Benzimidazoles; Biomarkers, Tumor; Blotting, Western; Cell Culture Techniques; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Clinical Trials as Topic; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Lymphoma, T-Cell, Cutaneous; Polo-Like Kinase 1; Prognosis; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Skin Neoplasms; Thiophenes | 2011 |
Targeting Plk1 in cutaneous T-cell lymphomas (CTCLs).
Topics: Benzimidazoles; cdc25 Phosphatases; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Cyclin B1; G2 Phase; Humans; Lymphoma, T-Cell, Cutaneous; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; RNA Interference; RNA, Small Interfering; Thiophenes | 2011 |
Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication.
Topics: Antiviral Agents; Dose-Response Relationship, Drug; Glutathione; HIV Reverse Transcriptase; HIV-1; Humans; Kinetics; Lymphoma, T-Cell, Cutaneous; Molecular Structure; NAD(P)H Dehydrogenase (Quinone); Pyrazines; Reverse Transcriptase Inhibitors; Skin Neoplasms; Thiones; Thiophenes; Time Factors; Tumor Cells, Cultured; Virus Replication; Zidovudine | 1993 |